Patents by Inventor Seon Ah HWANG

Seon Ah HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF
    Publication number: 20240317730
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Application
    Filed: June 1, 2024
    Publication date: September 26, 2024
    Applicant: Voronoi Inc.
    Inventors: Youn Ho Lee, Seon Ah Hwang, In Seob Shim, Hyeon Ho Jeon, Woo Mi Do, Hee Sun Ryu, Jung Beom Son, Nam Doo Kim, Sung Hwan Kim, Hong Ryul Jung, Young Yi Lee
  • Heteroaryl derivative compounds, and uses thereof
    Patent number: 12037330
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: July 16, 2024
    Assignee: Voronoi Inc.
    Inventors: Youn Ho Lee, Seon Ah Hwang, In Seob Shim, Hyeon Ho Jeon, Woo Mi Do, Hee Sun Ryu, Jung Beom Son, Nam Doo Kim, Sung Hwan Kim, Hong Ryul Jung, Young Yi Lee
  • HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF
    Publication number: 20240166640
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 23, 2024
    Applicant: Voronoi Inc.
    Inventors: Youn Ho LEE, Seon Ah Hwang, In Seob Shim, Hyeon Ho Jeon, Woo Mi Do, Hee Sun Ryu, Jung Beom Son, Nam Doo Kim, Sung Hwan Kim, Hong Ryul Jung, Young Yi Lee
  • HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF
    Publication number: 20240025888
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Application
    Filed: May 16, 2022
    Publication date: January 25, 2024
    Applicant: Voronoi Inc.
    Inventors: Youn Ho LEE, Seon Ah HWANG, In Seob SHIM, Hyeon Ho JEON, Woo Mi DO, Hee Sun RYU, Jung Beom SON, Nam Doo KIM, Sung Hwan KIM, Hong Ryul JUNG, Young Yi LEE